Prader Willi Syndrome clinical trials

Explore recruiting prader willi syndrome clinical trials.

Recruiting prader willi syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prader Willi Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Spain, Germany, Italy, Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome

Poland, Sweden, Italy, France, Germany, Romania +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of PBF-999 in the Treatment of Patients with Prader-Willi Syndrome.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

LONG-TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AND COMPARISON WITH AN UNTREATED COHORT OF CHILDREN WITH PRADER-WILLI SYNDROME (OTBB3 FOLLOW-UP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Germany, Spain, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prader Willi Syndrome trials by city

Prader Willi Syndrome in Toronto Prader Willi Syndrome in Vancouver Prader Willi Syndrome in Montreal Prader Willi Syndrome in Calgary Prader Willi Syndrome in Edmonton Prader Willi Syndrome in Ottawa Prader Willi Syndrome in Winnipeg Prader Willi Syndrome in Quebec City Prader Willi Syndrome in Hamilton Prader Willi Syndrome in Kitchener Prader Willi Syndrome in London Prader Willi Syndrome in Halifax Prader Willi Syndrome in New York Prader Willi Syndrome in Los Angeles Prader Willi Syndrome in Chicago Prader Willi Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease